HighTower Advisors
EXAS

HighTower Advisors’s Exact Sciences EXAS Stock Holding History

HighTower Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,227,761
Closed -$125M – 3850
2025
Q4 		$125M Sell
1,227,761
-2,195
-0.2% -$176K 0.14% 153
2025
Q3 		$67.3M Buy
1,229,956
+695,807
+130% +$34.8M 0.08% 266
2025
Q2 		$28.4M Buy
534,149
+4,276
+0.8% +$217K 0.04% 471
2025
Q1 		$22.9M Sell
529,873
-265
-0% -$13.4K 0.03% 492
2024
Q4 		$29.8M Buy
530,138
+23,791
+5% +$1.48M 0.04% 413
2024
Q3 		$34.5M Sell
506,347
-1,049
-0.2% -$59.2K 0.05% 369
2024
Q2 		$21.4M Sell
507,396
-9,044
-2% -$498K 0.03% 473
2024
Q1 		$35.7M Sell
516,440
-1,038
-0.2% -$65.7K 0.06% 326
2023
Q4 		$38.3M Sell
517,478
-8,096
-2% -$531K 0.06% 300
2023
Q3 		$35.9M Buy
525,574
+758
+0.1% +$64.3K 0.07% 285
2023
Q2 		$49.3M Sell
524,816
-6,789
-1% -$530K 0.1% 214
2023
Q1 		$36M Sell
531,605
-1,027
-0.2% -$66K 0.08% 264
2022
Q4 		$26.4M Sell
532,632
-4,048
-0.8% -$165K 0.06% 315
2022
Q3 		$17.4M Sell
536,680
-2,147
-0.4% -$88.5K 0.05% 385
2022
Q2 		$21.2M Buy
538,827
+18,826
+4% +$1.01M 0.05% 328
2022
Q1 		$36.4M Buy
520,001
+428,049
+466% +$31.3M 0.08% 253
2021
Q4 		$7.16M Buy
91,952
+2,198
+2% +$194K 0.02% 736
2021
Q3 		$8.57M Buy
89,754
+769
+0.9% +$81.2K 0.02% 601
2021
Q2 		$11.1M Buy
88,985
+1,661
+2% +$198K 0.03% 482
2021
Q1 		$11.5M Sell
87,324
-29,015
-25% -$3.97M 0.04% 438
2020
Q4 		$15.4M Sell
116,339
-160,812
-58% -$19.4M 0.06% 282
2020
Q3 		$28.3M Sell
277,151
-317
-0.1% -$27.4K 0.14% 160
2020
Q2 		$24.1M Sell
277,468
-3,373
-1% -$269K 0.13% 167
2020
Q1 		$16.3M Buy
280,841
+47,830
+21% +$3.88M 0.11% 196
2019
Q4 		$21.5M Sell
233,011
-6,075
-3% -$534K 0.13% 177
2019
Q3 		$21.6M Sell
239,086
-2,520
-1% -$287K 0.12% 181
2019
Q2 		$28.5M Sell
241,606
-5,728
-2% -$577K 0.17% 130
2019
Q1 		$21.4M Buy
247,334
+7,802
+3% +$664K 0.14% 152
2018
Q4 		$15.1M Sell
239,532
-608
-0.3% -$41.7K 0.12% 189
2018
Q3 		$19M Sell
240,140
-12,452
-5% -$812K 0.14% 165
2018
Q2 		$15.1M Sell
252,592
-400
-0.2% -$21.5K 0.12% 191
2018
Q1 		$10.2M Sell
252,992
-861
-0.3% -$42K 0.09% 257
2017
Q4 		$13.3M Sell
253,853
-32,049
-11% -$1.71M 0.11% 197
2017
Q3 		$13.5M Buy
285,902
+2,119
+0.7% +$85.3K 0.11% 186
2017
Q2 		$10M Sell
283,783
-3,720
-1% -$115K 0.09% 246
2017
Q1 		$6.79M Buy
287,503
+6,251
+2% +$124K 0.07% 333
2016
Q4 		$3.76M Buy
281,252
+3,113
+1% +$50.3K 0.04% 488
2016
Q3 		$5.17M Sell
278,139
-17,425
-6% -$307K 0.06% 346
2016
Q2 		$3.62M Sell
295,564
-25,400
-8% -$191K 0.05% 430
2016
Q1 		$2.16M Buy
320,964
+71,457
+29% +$457K 0.01% 691
2015
Q4 		$2.31M Buy
249,507
+85,600
+52% +$796K 0.03% 588
2015
Q3 		$2.95M Sell
163,907
-1,644
-1% -$37.8K 0.04% 474
2015
Q2 		$4.92M Sell
165,551
-126,080
-43% -$3.17M 0.08% 273
2015
Q1 		$6.42M Sell
291,631
-8,042
-3% -$204K 0.1% 229
2014
Q4 		$8.22M Sell
299,673
-83,416
-22% -$2.03M 0.13% 186
2014
Q3 		$7.42M Buy
383,089
+48,664
+15% +$892K 0.13% 193
2014
Q2 		$5.7M Buy
334,425
+107,115
+47% +$1.47M 0.1% 221
2014
Q1 		$3.22M Sell
227,310
-26,049
-10% -$352K 0.06% 354
2013
Q4 		$2.98M Sell
253,359
-4,687
-2% -$53.8K 0.06% 341
2013
Q3 		$3.04M Buy
258,046
+112,710
+78% +$1.45M 0.08% 297
2013
Q2 		$2.02M Buy
+145,336
New +$1.58M 0.06% 391

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

HighTower Advisors's EXAS Position: Q1 2026 in Review

HighTower Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,227,761 shares — an estimated $125M sold.

HighTower Advisors first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HighTower Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 1,227,761 Exact Sciences shares in Q1 2026, an estimated $125M.
  • HighTower Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • HighTower Advisors's Exact Sciences position peaked at $125M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.